Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Swedish double mutation (KM670/671NL) of amyloid precursor protein (Swe‐APP), a prevailing cause of familial Alzheimer's disease (FAD), is known to increase in Aβ production both in vitro and in vivo, but its underlying molecular basis leading to Alzheimer's disease (AD) pathogenesis remains to be elucidated, especially for the early phase of disease. We have confirmed initially that the expression of Swe‐APP mutant transgene reduced cell viability via ROS production but this effect was eliminated by an anti‐oxidative agent, vitamin E. We also found that eukaryotic translation initiation factor‐2α (eIF2α), which facilitates binding of initiator tRNA to ribosomes to set on protein synthesis, was phosphorylated in cultured cells expressing Swe‐APP. This increase in phosphorylated eIF2α was also attenuated significantly by treatment with vitamin E. The finding that eIF2α became highly phosphorylated by increased production of Aβ was substantiated in brain tissues of both an AD animal model and AD patients. Although an increase in Aβ production would result in cell death eventually (in late‐phase of the disease), the altered phosphorylation state of eIF2α evoked by Aβ may account for the decreased efficacy of mRNA translation and de novo protein synthesis required for synaptic plasticity, and may consequently be one of molecular causes for impairment of cognitive functions exhibited in the early phase of AD patients. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946 · cited 1×
“These deficits, however, were accompanied by no loss of presynaptic or postsynaptic structural elements in the hippocampus (Chapman et al., 1999).”
BackgroundER stress and neurodegenerative diseases
Lindholm, D., Wootz, H., & Korhonen, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401778 · Cited by 882 · cited 2×
“…amyloid precursor protein; ROS; eucaryotic translation initiation factor-2a; synaptic plasticity Alzheimer’s disease (AD) is a devastating neurodegenerative disease characterized by the progressive decline of memory and cognitive ability (Yankner et al., 1996; Selkoe, 2001; Lindholm et al., 2006).”
BackgroundAllan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
NMDA receptors, place cells and hippocampal spatial memory
Nakazawa, K., McHugh, T. J., Wilson, M. A., & Tonegawa, S. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1385 · Cited by 619 · cited 2×
“Because a distinct role for each hippocampal subregion in spatial memory has been postulated (Nakazawa et al., 2004), the differential phosphorylation of eIF2a that we observed may be related with a region-specific network lesion (and failed in specific forms of memory) observed normally in the early-phase of AD.”
BackgroundRibosome Dysfunction Is an Early Event in Alzheimer's Disease
Ding, Q., Markesbery, W. R., Chen, Q., Li, F., & Keller, J. N. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3040-05.2005 · Cited by 433
Li, X., Alafuzoff, I., Soininen, H., Winblad, B., & Pei, J. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04833.x · Cited by 324 · cited 1×
“4C), consistent with previous reports (Chang et al., 2002a; Li et al., 2005).”
Chang, R. C. C., Wong, A. K. Y., Ng, H.-K., & Hugon, J. (2002) · NeuroReport · doi:10.1097/00001756-200212200-00011 · Cited by 289 · cited 4×
“This finding was consistent with other reports that phosphorylated forms of eIF2a and PKR, an eIF2a kinase, were upregulated in autopsied hippocampus of AD patients (Chang et al., 2002a; Peel and Bredesen, 2003; Onuki et al., 2004).”
BackgroundResultInfluentialChang, R. C., Suen, K., Ma, C., Elyaman, W., Ng, H., & Hugon, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01237.x · Cited by 180 · cited 7×
“A physiologic outcome for the phosphorylation of eIF2a could be that an increase in p-eIF2a elicits neuronal apoptosis, as proposed previously (Chang et al., 2002a).”
BackgroundResultInfluentialPeel, A. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00086-x · Cited by 125
Cited by
Making synaptic plasticity and memory last: mechanisms of translational regulation
Richter, J. D., & Klann, E. (2009) · Genes & Development · doi:10.1101/gad.1735809 · Cited by 348
Ricobaraza, A., Cuadrado‐Tejedor, M., Marco, S., Pérez‐Otaño, I., & García‐Osta, A. (2012) · Hippocampus · doi:10.1002/hipo.20883 · Cited by 239
“In agreement with previous findings, we found that phosphorylation of eIF2a was significantly increased in the hippocampi of 12-to 16-month-old Tg2576 mice compared to age-matched non-transgenic mice (Figs. 4B,E, P < 0.001 vs. saline treated Tg2576 mice; Kim et al., 2007).”
BackgroundResultInfluentialActivation of mTOR: a culprit of Alzheimer’s disease?
Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161
Devi, L., Alldred, M. J., Ginsberg, S. D., & Ohno, M. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-34 · Cited by 129
“Increases in phospho-eIF2a levels occur in brains of sporadic AD and advanced pathological stages of APP transgenic mice including the 5XFAD model [24-26,45,46] and are shown to correlate with BACE1 elevation [25,26].”
BackgroundBriggs, D. I., Defensor, E., Memar Ardestani, P., Yi, B., Halpain, M., Seabrook, G., & Shamloo, M. (2017) · eneuro · doi:10.1523/eneuro.0025-17.2017 · Cited by 61
“This was surprising since previously it was reported that eIF2 phosphorylation can occur in response to A in cultured cells expressing Swe-APP (Kim et al., 2007).”
Background
Metadata
- Authors
- Kim, H., Choi, Y., Shin, K., Joo, Y., Lee, Y., Jung, S. Y., Suh, Y., & Kim, J.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2007-03-28
- Volume
- 85
- Issue
- 7
- Pages
- 1528-1537
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2046885716
- Cited by
- 52
- References
- 9
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.